Asit Parikh, Director at Phathom Pharmaceuticals, Inc. (PHAT), bought 20,000 shares at $8.12 ($162K) on 2024-12-13, disclosed to the SEC on 2024-12-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.12 | 10,000 | $81K | 50.0% |
| 2 | $8.12 | 10,000 | $81K | 50.0% |
| Total | $8.12 avg | 20,000 | $162K | 100% |
| Filing → |
| PHAT | BUY | 2023-11-08 | $59K | — | Filing → |
| PHAT | BUY | 2023-04-11 | $8K | — | Filing → |
| PHAT | BUY | 2023-02-14 | $39K | — | Filing → |